| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/07/2010 | EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound |
| 04/07/2010 | EP2172197A1 Octanoic acid derivative to treat fibromyalgia and other pains |
| 04/07/2010 | EP2171095A1 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof |
| 04/07/2010 | EP2170828A1 Substituted n-aryl pyridinones as fibrotic inhibitors |
| 04/07/2010 | EP2170374A2 Method for treating diseases related to mitochondrial dysfunction |
| 04/07/2010 | EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 04/07/2010 | EP1423150B1 Sustained release of microcrystalline peptide suspensions |
| 04/07/2010 | EP1313448B1 Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
| 04/07/2010 | CN1569869B Chinese chestnut flower flavone compounds |
| 04/07/2010 | CN1545551B Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 04/07/2010 | CN101691548A Isolation and culture method and application of Agrobaterium isolate |
| 04/07/2010 | CN101691370A Triazolo[4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 04/07/2010 | CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor |
| 04/07/2010 | CN101690766A Gentle bath foam traditional Chinese medicine composite, preparation method thereof and application thereof in preparing drugs and health care products to cure cold-type fatigue syndrome and obesity |
| 04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
| 04/06/2010 | US7691906 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock |
| 04/06/2010 | US7691903 Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
| 04/06/2010 | US7691884 Heterocyclic sulfonamide inhibitors of β amyloid production |
| 04/06/2010 | US7691883 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 04/06/2010 | US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure |
| 04/06/2010 | US7691843 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 04/06/2010 | US7691842 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors |
| 04/06/2010 | US7691804 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth |
| 04/06/2010 | US7691593 Regulation of lung tissue by patched therapeutics and formulations and uses related thereto |
| 04/06/2010 | US7691568 Antibody composition-containing medicament |
| 04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
| 04/06/2010 | CA2513738C Casr antagonist |
| 04/06/2010 | CA2464846C Dibenzylamine compounds and pharmaceutical use thereof |
| 04/06/2010 | CA2459009C Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 04/06/2010 | CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives |
| 04/06/2010 | CA2453383C Piperidine derivatives as nmda receptor antagonists |
| 04/06/2010 | CA2449899C Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 04/06/2010 | CA2416220C Preparation of phosphatase inhibitors |
| 04/06/2010 | CA2331274C Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 04/06/2010 | CA2280873C The use of latency associated peptide in wound healing |
| 04/06/2010 | CA2258675C 2-cyclopenten-1-one as an inducer of hsp70 |
| 04/01/2010 | WO2010037122A1 Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods |
| 04/01/2010 | WO2010037066A2 Dosage units of 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 04/01/2010 | WO2010035675A1 Immunopotentiator or antiallergic agent |
| 04/01/2010 | WO2010035575A1 Melanin production inhibitor and skin-whitening cosmetic |
| 04/01/2010 | WO2010035052A1 Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification |
| 04/01/2010 | WO2010035026A1 Use of nmda activity enhancers to treat hypersomnia, reduced wakefulness or reduced vigilance |
| 04/01/2010 | WO2010034779A2 Composition and method for treatment of preterm labor |
| 04/01/2010 | WO2010001102A3 Photochemical internalisation of kinase inhibitors |
| 04/01/2010 | WO2008139845A8 Novel amide derivative |
| 04/01/2010 | US20100083393 Method of constructing clone mammal |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081718 Combinations comprising alpha-2-delta ligands |
| 04/01/2010 | US20100081710 Modified L-Nucleic Acid |
| 04/01/2010 | US20100081709 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses |
| 04/01/2010 | US20100081696 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 04/01/2010 | US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter |
| 04/01/2010 | US20100081667 Chemical Compounds |
| 04/01/2010 | US20100081639 Pharmaceutical composition comprising fermented ginseng |
| 04/01/2010 | US20100081624 Selective peptides that inhibit the biological activity of calcineurin |
| 04/01/2010 | US20100081618 Transporters Comprising Spaced Arginine Moieties |
| 04/01/2010 | US20100080862 Compositions and foods for improving lipid metabolism |
| 04/01/2010 | US20100080858 Anti-hypothermia composition |
| 04/01/2010 | US20100080847 Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same |
| 04/01/2010 | US20100080829 Lyophilized pharmaceutical compositions and methods of making and using same |
| 04/01/2010 | US20100080821 Energy Compositions |
| 04/01/2010 | US20100080819 Modulators of p-selectin glycoprotein ligand 1 |
| 04/01/2010 | US20100080804 Methods of treating inflammatory disorders of the lungs |
| 04/01/2010 | US20100080803 Labor biomarkers, methods comprising same, and methods targeting same |
| 04/01/2010 | US20100080796 Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
| 04/01/2010 | US20100080793 DcR3 polypeptide, A TNFR homolog |
| 04/01/2010 | US20100080784 Methods for treating cachexia and lymphopenia |
| 04/01/2010 | US20100080783 Microbial feed additive |
| 04/01/2010 | CA2738605A1 Composition and method for treatment of preterm labor |
| 04/01/2010 | CA2737077A1 Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods |
| 04/01/2010 | CA2736545A1 Dosage units of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/31/2010 | EP2169060A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/31/2010 | EP2168972A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 03/31/2010 | EP2168966A1 Bicycloaniline derivative |
| 03/31/2010 | EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 03/31/2010 | EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof |
| 03/31/2010 | EP2168957A2 Alkyl-substituted tetrahydropyranes as aromatic materials |
| 03/31/2010 | EP2168952A1 Morpholine derivative |
| 03/31/2010 | EP2168950A1 Inhibitor of the differentiation of t cells into th1 cells |
| 03/31/2010 | EP2168948A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 03/31/2010 | EP2168947A1 Novel compound having secretase inhibitory activity |
| 03/31/2010 | EP2168944A1 Amine compound and pharmaceutical use thereof |
| 03/31/2010 | EP2168600A1 Therapeutic or prophylactic agent for cerebral aneurysm |
| 03/31/2010 | EP2168598A1 Method of Treatment Using Ligand-Immunogen Conjugates |
| 03/31/2010 | EP2168581A2 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 03/31/2010 | EP2168577A1 Drug having effect of promoting hepatocyte growth |
| 03/31/2010 | EP2167109A2 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue |
| 03/31/2010 | EP1758596B1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 03/31/2010 | EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF |
| 03/31/2010 | EP1530724B1 Diagnosis and prevention of cancer cell invasion |
| 03/31/2010 | EP1333823B1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 03/31/2010 | EP1223923B1 Unsaturated aryl sulfones for protecting normal cells from cytotoxicity of chemotherapeutic agents |
| 03/31/2010 | EP1194168B1 Methods and products for manipulating uncoupling protein expression |
| 03/31/2010 | EP1107989B1 Expression and export of angiostatin and endostatin as immunofusins |
| 03/31/2010 | CN101687843A Substituted aromatic heterocyclic compounds as fungicides |
| 03/31/2010 | CN101687800A glucokinase activator |
| 03/31/2010 | CN101687104A Cancer treatment combination therapy comprising vinflunine and trastuzumab |